Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
34
MRNA Quote, Financials, Valuation and Earnings
Last price:
$32.74
Seasonality move
:
5%
Day range:
$32.14 - $34.97
52-week range:
$22.28 - $48.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.60x
P/B ratio:
1.35x
Volume:
11.9M
Avg. volume:
10.7M
1-year change:
-18.44%
Market cap:
$12.6B
Revenue:
$3.2B
EPS (TTM):
-$8.06
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $803.4M | $18.4B | $19.1B | $6.8B | $3.2B | |
| Revenue Growth (YoY) | 1234.34% | 2191.9% | 3.78% | -64.21% | -52.69% | |
| Cost of Revenues | $39.2M | $2.8B | $5.8B | $5.3B | $1.7B | |
| Gross Profit | $764.2M | $15.6B | $13.3B | $1.5B | $1.6B | |
| Gross Profit Margin | 95.12% | 84.53% | 69.84% | 22.31% | 48.92% | |
| R&D Expenses | $1.3B | $1.8B | $2.9B | $4.2B | $4.4B | |
| Selling, General & Admin | $188.3M | $567M | $1.1B | $1.5B | $1.2B | |
| Other Inc / (Exp) | -$6M | -$29M | -$45M | -$86M | -$63M | |
| Operating Expenses | $1.5B | $2.3B | $4.1B | $5.8B | $5.5B | |
| Operating Income | -$763.1M | $13.2B | $9.3B | -$4.2B | -$3.9B | |
| Net Interest Expenses | $9.9M | $18M | $29M | $38M | $24M | |
| EBT. Incl. Unusual Items | -$744.5M | $13.3B | $9.6B | -$3.9B | -$3.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.6M | $1.1B | $1.2B | $772M | -$46M | |
| Net Income to Company | -$747.1M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$747.1M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Basic EPS (Cont. Ops) | -$1.96 | $30.28 | $21.22 | -$12.34 | -$9.27 | |
| Diluted EPS (Cont. Ops) | -$1.96 | $28.31 | $20.10 | -$12.34 | -$9.27 | |
| Weighted Average Basic Share | $381.3M | $403M | $394M | $382M | $384M | |
| Weighted Average Diluted Share | $381.3M | $431M | $416M | $382M | $384M | |
| EBITDA | -$731.9M | $13.5B | $9.6B | -$3.6B | -$3.8B | |
| EBIT | -$763.1M | $13.2B | $9.3B | -$4.2B | -$3.9B | |
| Revenue (Reported) | $803.4M | $18.4B | $19.1B | $6.8B | $3.2B | |
| Operating Income (Reported) | -$763.1M | $13.2B | $9.3B | -$4.2B | -$3.9B | |
| Operating Income (Adjusted) | -$763.1M | $13.2B | $9.3B | -$4.2B | -$3.9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5B | $3.3B | $1.8B | $1.9B | $1B | |
| Revenue Growth (YoY) | 3046.73% | -33.31% | -44.75% | 1.69% | -45.44% | |
| Cost of Revenues | $792M | $1.2B | $2.5B | $566M | $259M | |
| Gross Profit | $4.2B | $2.1B | -$659M | $1.3B | $757M | |
| Gross Profit Margin | 84.06% | 63.4% | -35.99% | 69.6% | 74.51% | |
| R&D Expenses | $451M | $707M | $911M | $1.1B | $749M | |
| Selling, General & Admin | $168M | $278M | $442M | $281M | $268M | |
| Other Inc / (Exp) | -$6M | $1M | -$41M | -$6M | -- | |
| Operating Expenses | $619M | $985M | $1.4B | $1.4B | $1B | |
| Operating Income | $3.6B | $1.1B | -$2B | -$70M | -$260M | |
| Net Interest Expenses | $4M | $8M | $10M | $6M | -- | |
| EBT. Incl. Unusual Items | $3.6B | $1.2B | -$2B | $21M | -$187M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $219M | $174M | $1.7B | $8M | $13M | |
| Net Income to Company | $3.3B | $1B | -$3.6B | $13M | -$200M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.3B | $1B | -$3.6B | $13M | -$200M | |
| Basic EPS (Cont. Ops) | $8.25 | $2.67 | -$9.53 | $0.03 | -$0.51 | |
| Diluted EPS (Cont. Ops) | $7.68 | $2.53 | -$9.53 | $0.03 | -$0.51 | |
| Weighted Average Basic Share | $404M | $390M | $381M | $385M | $390M | |
| Weighted Average Diluted Share | $434M | $412M | $381M | $399M | $390M | |
| EBITDA | $3.6B | $1.2B | -$1.8B | -$18M | -$208M | |
| EBIT | $3.6B | $1.1B | -$2B | -$70M | -$260M | |
| Revenue (Reported) | $5B | $3.3B | $1.8B | $1.9B | $1B | |
| Operating Income (Reported) | $3.6B | $1.1B | -$2B | -$70M | -$260M | |
| Operating Income (Adjusted) | $3.6B | $1.1B | -$2B | -$70M | -$260M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $11.8B | $21.2B | $9.1B | $5.1B | $2.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.8B | $4.8B | $6.2B | $2B | $1.4B | |
| Gross Profit | $10B | $16.4B | $2.9B | $3.1B | $869M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.9B | $2.4B | $4.2B | $4.5B | $3.3B | |
| Selling, General & Admin | $445M | $958M | $1.5B | $1.3B | $1.1B | |
| Other Inc / (Exp) | -$10M | -$33M | -$84M | -$73M | -- | |
| Operating Expenses | $2.4B | $3.3B | $5.6B | $5.8B | $4.3B | |
| Operating Income | $7.6B | $13.1B | -$2.7B | -$2.7B | -$3.5B | |
| Net Interest Expenses | $15.5M | $25M | $42M | $24M | $8M | |
| EBT. Incl. Unusual Items | $7.6B | $13.3B | -$2.4B | -$2.4B | -$3.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $542.5M | $1.6B | $1.1B | -$129M | -$37M | |
| Net Income to Company | $7.1B | $11.8B | -$3.5B | -$2.2B | -$3.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $7.1B | $11.8B | -$3.5B | -$2.2B | -$3.1B | |
| Basic EPS (Cont. Ops) | $17.53 | $29.34 | -$9.14 | -$5.80 | -$8.06 | |
| Diluted EPS (Cont. Ops) | $16.28 | $27.65 | -$9.34 | -$5.82 | -$8.06 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $7.8B | $13.4B | -$2.2B | -$2.4B | -$3.3B | |
| EBIT | $7.6B | $13.1B | -$2.7B | -$2.7B | -$3.5B | |
| Revenue (Reported) | $11.8B | $21.2B | $9.1B | $5.1B | $2.2B | |
| Operating Income (Reported) | $7.6B | $13.1B | -$2.7B | -$2.7B | -$3.5B | |
| Operating Income (Adjusted) | $7.6B | $13.1B | -$2.7B | -$2.7B | -$3.5B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $11.3B | $14.1B | $4B | $2.3B | $1.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.8B | $3.8B | $4.2B | $854M | $564M | |
| Gross Profit | $9.4B | $10.3B | -$136M | $1.4B | $702M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $1.2B | $1.8B | $3B | $3.3B | $2.2B | |
| Selling, General & Admin | $366M | $757M | $1.1B | $823M | $710M | |
| Other Inc / (Exp) | -$10M | -$14M | -$53M | -$40M | $6M | |
| Operating Expenses | $1.6B | $2.6B | $4.1B | $4.1B | $2.9B | |
| Operating Income | $7.9B | $7.7B | -$4.2B | -$2.7B | -$2.2B | |
| Net Interest Expenses | $12M | $19M | $32M | $18M | $2M | |
| EBT. Incl. Unusual Items | $7.9B | $7.9B | -$4B | -$2.4B | -$2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $541M | $1B | $919M | $18M | $27M | |
| Net Income to Company | $7.3B | $6.9B | -$4.9B | -$2.4B | -$2B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $7.3B | $6.9B | -$4.9B | -$2.4B | -$2B | |
| Basic EPS (Cont. Ops) | $18.22 | $17.32 | -$12.94 | -$6.37 | -$5.15 | |
| Diluted EPS (Cont. Ops) | $16.97 | $16.36 | -$12.95 | -$6.37 | -$5.15 | |
| Weighted Average Basic Share | $1.2B | $1.2B | $1.1B | $1.2B | $1.2B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B | |
| EBITDA | $8B | $8B | -$3.8B | -$2.6B | -$2.1B | |
| EBIT | $7.9B | $7.7B | -$4.2B | -$2.7B | -$2.2B | |
| Revenue (Reported) | $11.3B | $14.1B | $4B | $2.3B | $1.3B | |
| Operating Income (Reported) | $7.9B | $7.7B | -$4.2B | -$2.7B | -$2.2B | |
| Operating Income (Adjusted) | $7.9B | $7.7B | -$4.2B | -$2.7B | -$2.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.6B | $10.7B | $9.9B | $8.6B | $7B | |
| Short Term Investments | $2B | $3.9B | $6.7B | $5.7B | $5.1B | |
| Accounts Receivable, Net | $1.4B | $3.2B | $1.4B | $892M | $358M | |
| Inventory | $46.5M | $1.4B | $949M | $202M | $117M | |
| Prepaid Expenses | $15.6M | $126M | $403M | $182M | $201M | |
| Other Current Assets | $11M | $26M | $44M | $88M | $58M | |
| Total Current Assets | $6.3B | $16.1B | $13.4B | $10.3B | $8.1B | |
| Property Plant And Equipment | $387.1M | $1.4B | $2.1B | $2.7B | $3B | |
| Long-Term Investments | $649.9M | $6.9B | $8.4B | $4.8B | $2.6B | |
| Goodwill | -- | -- | -- | $52M | $52M | |
| Other Intangibles | -- | -- | -- | $44M | $40M | |
| Other Long-Term Assets | $13M | $46M | $946M | $181M | $171M | |
| Total Assets | $7.3B | $24.9B | $26.1B | $18.4B | $14.1B | |
| Accounts Payable | $18.4M | $302M | $487M | $520M | $405M | |
| Accrued Expenses | $375M | $1.3B | $1.9B | $997M | $745M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $30M | $211M | $196M | $25M | $37M | |
| Other Current Liabilities | $4M | $14M | $53M | $41M | $181M | |
| Total Current Liabilities | $4.4B | $9.1B | $4.9B | $3B | $2.2B | |
| Long-Term Debt | $207.3M | $705M | $1B | $1.2B | $710M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.8B | $10.7B | $7B | $4.6B | $3.2B | |
| Common Stock | $40K | -- | -- | -- | -- | |
| Other Common Equity Adj | $3M | -$24M | -$370M | -$123M | -$10M | |
| Common Equity | $2.6B | $14.1B | $19.1B | $13.9B | $10.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.6B | $14.1B | $19.1B | $13.9B | $10.9B | |
| Total Liabilities and Equity | $7.3B | $24.9B | $26.1B | $18.4B | $14.1B | |
| Cash and Short Terms | $4.6B | $10.7B | $9.9B | $8.6B | $7B | |
| Total Debt | $231.6M | $870M | $1.2B | $1.2B | $733M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.9B | $8.3B | $7.6B | $6.9B | $4.5B | |
| Short Term Investments | $3.4B | $5.3B | $4.6B | $5.2B | -- | |
| Accounts Receivable, Net | $3.1B | $2.7B | $1.9B | $1.6B | $1B | |
| Inventory | $965M | $2.1B | $487M | $412M | $332M | |
| Prepaid Expenses | $105M | $540M | $397M | $312M | $235M | |
| Other Current Assets | $43M | $85M | $96M | $46M | -- | |
| Total Current Assets | $13.4B | $14.3B | $10.8B | $9.7B | $6.6B | |
| Property Plant And Equipment | $960M | $2.1B | $2.7B | $3.2B | $2.9B | |
| Long-Term Investments | $6.5B | $8.7B | $5.4B | $2.4B | $2.3B | |
| Goodwill | -- | -- | $52M | $52M | -- | |
| Other Intangibles | -- | -- | $45M | $41M | -- | |
| Other Long-Term Assets | $15M | $52M | $240M | $85M | -- | |
| Total Assets | $20.9B | $26.1B | $19.5B | $15.8B | $12.1B | |
| Accounts Payable | $87M | $330M | $494M | $373M | $267M | |
| Accrued Expenses | $971M | $1.7B | $1.8B | $729M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $240M | $260M | $183M | $51M | -- | |
| Other Current Liabilities | $12M | $293M | $56M | $18M | -- | |
| Total Current Liabilities | $10B | $6.8B | $4.4B | $2.2B | $1.7B | |
| Long-Term Debt | $343M | $1B | $1.3B | $1.3B | $686M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $10.8B | $8.1B | $6B | $3.9B | $2.8B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $31M | -$351M | -$211M | $11M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $10.1B | $18B | $13.5B | $11.9B | $9.3B | |
| Total Liabilities and Equity | $20.9B | $26.1B | $19.5B | $15.8B | $12.1B | |
| Cash and Short Terms | $8.9B | $8.3B | $7.6B | $6.9B | $4.5B | |
| Total Debt | $561M | $1.2B | $1.4B | $1.3B | $717M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$747.1M | $12.2B | $8.4B | -$4.7B | -$3.6B | |
| Depreciation & Amoritzation | $31.3M | $232M | $348M | $621M | $189M | |
| Stock-Based Compensation | $93M | $142M | $226M | $305M | $429M | |
| Change in Accounts Receivable | -$1.4B | -$1.8B | $1.8B | $493M | $534M | |
| Change in Inventories | -$46.5M | -$1.4B | $492M | $747M | $83M | |
| Cash From Operations | $2B | $13.6B | $5B | -$3.1B | -$3B | |
| Capital Expenditures | $67.4M | $284M | $400M | $707M | $1.1B | |
| Cash Acquisitions | -- | -- | -- | $85M | -- | |
| Cash From Investing | -$1.7B | -$8.5B | -$5.2B | $4.2B | $1.9B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $857M | $3.3B | $1.2B | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $2B | -$873M | -$3.4B | -$1.4B | $56M | |
| Beginning Cash (CF) | $2.6B | $6.8B | $3.2B | $2.9B | $1.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.4B | $4.2B | -$3.6B | -$289M | -$999M | |
| Ending Cash (CF) | $5B | $11.1B | -$438M | $2.6B | $929M | |
| Levered Free Cash Flow | $2B | $13.3B | $4.6B | -$3.8B | -$4.1B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.3B | $1B | -$3.6B | $13M | -$200M | |
| Depreciation & Amoritzation | $70M | $113M | $249M | $52M | $52M | |
| Stock-Based Compensation | $40M | $70M | $77M | $112M | $125M | |
| Change in Accounts Receivable | -$1.1B | -$4M | -$1.6B | -$1.4B | -$1B | |
| Change in Inventories | -$322M | -$156M | $228M | -$11M | -$91M | |
| Cash From Operations | $3.3B | $252M | -$1.6B | -$1.6B | -$847M | |
| Capital Expenditures | $99M | $89M | $140M | $151M | $33M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.3B | $945M | $789M | $721M | $700M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | $62M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $1B | -$1M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$2M | -$1B | -$58M | $11M | -$1M | |
| Beginning Cash (CF) | $5.6B | $3B | $2.9B | $1.6B | $1.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$53M | $156M | -$869M | -$833M | -$147M | |
| Ending Cash (CF) | $5.5B | $3.2B | $2.1B | $811M | $986M | |
| Levered Free Cash Flow | $3.2B | $163M | -$1.7B | -$1.7B | -$880M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.1B | $11.8B | -$3.5B | -$2.2B | -$3.1B | |
| Depreciation & Amoritzation | $161.7M | $346M | $499M | $331M | $208M | |
| Stock-Based Compensation | $130.5M | $201M | $288M | $404M | $474M | |
| Change in Accounts Receivable | -$3B | $447M | $829M | $302M | $503M | |
| Change in Inventories | -$965M | -$1.1B | $1.6B | $77M | $78M | |
| Cash From Operations | $11.6B | $6.6B | -$2.1B | -$3.2B | -$2B | |
| Capital Expenditures | $187.3M | $428M | $579M | $749M | $685M | |
| Cash Acquisitions | -- | -- | $85M | -- | -- | |
| Cash From Investing | -$7.6B | -$5.3B | $3.7B | $2B | $1.5B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $3.8B | $1.6B | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $44.1M | -$3.9B | -$1.7B | -$50M | $9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4B | -$2.5B | -$88M | -$1.3B | -$513M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $11.4B | $6.2B | -$2.7B | -$4B | -$2.7B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.3B | $6.9B | -$4.9B | -$2.4B | -$2B | |
| Depreciation & Amoritzation | $154M | $268M | $419M | $129M | $148M | |
| Stock-Based Compensation | $105M | $164M | $226M | $325M | $370M | |
| Change in Accounts Receivable | -$1.8B | $480M | -$481M | -$672M | -$703M | |
| Change in Inventories | -$918M | -$636M | $462M | -$208M | -$213M | |
| Cash From Operations | $10.3B | $3.3B | -$3.7B | -$3.8B | -$2.8B | |
| Capital Expenditures | $164M | $308M | $487M | $529M | $163M | |
| Cash Acquisitions | -- | -- | $85M | -- | -- | |
| Cash From Investing | -$7.4B | -$4.1B | $4.7B | $2.5B | $2B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $2.9B | $1.2B | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$1M | |
| Cash From Financing | -- | -$3B | -$1.3B | $59M | $12M | |
| Beginning Cash (CF) | $16.6B | $10.9B | $10.2B | $6.2B | $4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.9B | -$3.8B | -$264M | -$1.3B | -$795M | |
| Ending Cash (CF) | $19.5B | $7.1B | $9.9B | $4.9B | $3.2B | |
| Levered Free Cash Flow | $10.1B | $3B | -$4.2B | -$4.4B | -$3B | |
Related Companies
Get MRNA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MRNA
Sector
P/E ratio
--
23.89x
PEG ratio
-0.10x
-0.01x
P/B ratio
1.35x
1.81x
Price / LTM sales
5.60x
1.59x
Growth Metrics
MRNA
Sector
Revenue growth
-45.44%
4.62%
Earnings growth
-1673.01%
11.06%
Revenue (5-year growth)
121.86%
6.5%
Earnings forecast
-$2.16
-$0.21
Profitability
MRNA
Sector
Profitability FY 2024
$1.6B
$3.6M
Return on invested capital
-27.85%
-31.84%
Return on assets
-23.33%
-27.96%
Return on equity
-30.18%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
12
Estimated Next Earnings Date
Feb
5
Balance Sheet
MRNA
Sector
Total cash
$4.5B
$26.4M
Short term investments
$5.1B
$25.7M
Total assets
$14.1B
$76.9M
Long term debt
$717M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
